A novel study from the Institute of Environmental Medicine at Karolinska Institutet indicates that antibodies against a small lipid entity, phosphorylcholine (PC), can be associated with ...

Now a new study shows how low levels of antibodies to the fatty substance phosphorylcholine, called anti-PC, may be a new independent risk marker for cardiovascular disease in older women.

"We can show that a low level of the natural antibody to phosphorylcholine can be used as a risk marker for cardiovascular disease also in women, independent of previously known risk factors.

The drug is released from a phosphorylcholine (PC) polymer that is coated on the Driver cobalt alloy stent. The drug is mainly localized on the arterial wall of the stent with a PC coating and ...